NCT06898970: An ongoing trial by Varun Monga, MBBS
This trial is ongoing. It must report results 4 years, 7 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06898970 |
|---|---|
| Title | An Open-Label, Multicenter, Phase 2 Study With Safety Lead-In of Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab in Patients With Angiosarcoma |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 31, 2025 |
| Completion date | July 31, 2029 |
| Required reporting date | July 31, 2030, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |